The webinar will focus on ‘COVID-19 in Rhinology and Allergy: Impact on smell and type 2 inflammation’. The general consensus is that COVID-19 has drastically affected rhinologic practice. PPE and the dangers associated with contracting the virus have meant a drastic overhaul of rhinologic clinical practices. 

The general consensus is that COVID-19 has drastically affected rhinologic practice [Image: master1305/Freepik].

  • Date: March 2nd 2021
  • Time: 6:30pm
  • Speaker: Prof Joaquim Mullol

CLICK TO REGISTER: http://bit.ly/Covid19RhinologyAllergyWebinar2MAR21

SCIENTIFIC BIOGRAPHY

Prof Joaquim Mullol, MD, PhD

Joaquim Mullol (Catalonia, Spain,1957) studied Medicine in the University of Barcelona where he obtained his medical degree (MD, 1982) and the doctorate (PhD, 1991). After completing the residency on Otorhinolaryngology (1984-88) in Barcelona, he carried out a Research Fellowship (1989-91) in the Allergic Disease Section and Asthma Center (LCI, NIAID) and Critical Care Medicine Department (CC), at the National Institutes of Health (Bethesda, USA). Currently,

Joaquim Mullol is Director of the Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic Barcelona; Professor of Research and Head of the Laboratory of Clinical and Experimental Respiratory Immunoallergy at IDIBAPS (August Pi I Sunyer Biomedical Research Institute); and Head of Research Group at CIBERES (Biomedical Research Network on Respiratory Diseases, Instituto de Salud Carlos III) in Barcelona, Catalonia, Spain. He has served as Secretary (2001-05) and Chairman (2005-07) of the ENT Section and member of the EAACI Executive Committee (2005-07). Currently, Prof Mullol is a member of the Executive Committees of MACVIA-ARIA, GA2LEN, EPOS, and the European Centre for Allergy Research Foundation (ECARF).

Joaquim Mullol has mainly focused his research on the mechanisms of action of upper airway inflammation (rhinitis, rhinosinusitis) with special interest in neurogenic inflammation, regulation of glandular secretion and mucin production, united airway diseases, impact of rhinitis and rhinosinusitis in patient’s quality of life, aspirin‐induced rhinosinusitis and asthma, stem cells and sinonasal epithelium regeneration, the epidemiology and pathophysiology of the loss of smell (including COVID‐19), and sinonasal stem/progenitor cell biology. Joaquim Mullol is author and co-author of more than 600 communications at national and international scientific congresses and meetings, and has published more than 250 peer-reviewed original articles, and over 160 review papers and guidelines in international scientific journals. He is currently the Rhinosinusitis Section Editor of Current Allergy and Asthma Reports and the Editor-in-Chief of Current Treatment Options in Allergy.